rel-((1R,2R)-2-aminocyclohexyl)methanol hydrochloride

Catalog No. :
ACLZPG364
CAS No. :
28250-45-5
Molecular Formula :
C7H16ClNO
Molecular Weight :
165.66

IUPAC Name:((1R,2R)-2-aminocyclohexyl)methanol hydrochloride

rel-((1R,2R)-2-aminocyclohexyl)methanol hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$355.00Login to see priceInquiryInquiry
250mg95%$472.00Login to see priceInquiryInquiry
500mg95%$786.00Login to see priceInquiryInquiry
1g95%$982.00Login to see priceInquiryInquiry
5g95%$3731.00Login to see priceInquiryInquiry
10g95%$6342.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-((1R,2R)-2-aminocyclohexyl)methanol hydrochloride
IUPAC Name((1R,2R)-2-aminocyclohexyl)methanol hydrochloride
MDL No.MFCD00145424
Molecular FormulaC7H16ClNO
Molecular Weight165.66
SMILESN[C@H]1[C@H](CO)CCCC1.[H]Cl
InChI KeyORPKUPNVXFLMRG-UOERWJHTSA-N
SynonymTRANS-2-HYDROXYMETHYL-1-CYCLOHEXYLAMINE HYDROCHLORIDE;TRANS-(2-AMINO-CYCLOHEXYL)-METHANOL HYDROCHLORIDE;trans-2-Hydroxymethylcyclohexanamine hydrochloride;trans-2-Hydroxymethylcyclohexylamine monohydrochloride;Rel-((1R,2R)-2-aminocyclohexyl)methanol hydrochloride;trans-2-hydroxymethyl-1-cyclohexylamineHCl;Trans-2-hydroxymethyl-1-cyclohexylamine hydrochloride, 99+%;CyclohexaneMethanol, 2-aMino-, hydrochloride, trans-
CAS No.28250-45-5

Synthetic Route by SureRoute

1. ACLZPG364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMIQZ618 route compound structure diagram
    ACMIQZ618158414-46-1 In Stock
  2. Then
  3. ACLZPG364 route product structure diagram
    ACLZPG36428250-45-5
Inquiry

2. ACLZPG364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLZPG364 route product structure diagram
    ACLZPG36428250-45-5
Inquiry

Comments (0)